Papilin: A Potential Cancer Drug Target (G89932)

Target Name: PAPLN

NCBI ID: G89932

PAPLN

Papilin: A Potential Cancer Drug Target

Papilin is a protein that is expressed in the epithelial tissue of the body, including the skin, gut, and respiratory tract. It is a small, transmembrane glycoprotein that consists of two chains: chain A and chain B. Each chain has a distinct function, and together they form a complex structure that is essential for cell signaling and tissue structure.

Papilin is a key regulator of cell signaling, particularly in the context of cell-cell adhesion. It plays a vital role in the formation of tight junctions, which are specialized junctions that mediate the transfer of electrical signals between adjacent cells. During development, papilin is involved in the formation of the neural tube, and it is also expressed in the placenta, where it plays a critical role in the exchange of nutrients and oxygen between the mother and the developing fetus.

Papilin is a protein that has been identified as a potential drug target in the field of cancer. Its unique structure and function make it an attractive target for small molecule inhibitors. In this article, we will explore the biology of papilin and its potential as a drug target.

Papilin Structure and Function

Papilin is a small protein that is expressed in the epithelial tissue of the body. It consists of two chains: chain A and chain B. Chain A is the N-terminus of the protein and contains a transmembrane domain. Chain B is the C-terminus of the protein and contains a cytoplasmic domain.

The transmembrane domain of papilin is a critical region that is involved in the regulation of cell signaling. It is composed of a region of coiled-coil structures, which are responsible for the formation of tight junctions. The cytoplasmic domain of papilin contains a region that is involved in the regulation of the cytoskeleton.

Papilin plays a vital role in the formation of tight junctions, which are specialized junctions that mediate the transfer of electrical signals between adjacent cells. During development, papilin is involved in the formation of the neural tube, and it is also expressed in the placenta, where it plays a critical role in the exchange of nutrients and oxygen between the mother and the developing fetus.

Papilin is also involved in the regulation of cell signaling, particularly in the context of cell-cell adhesion. It plays a vital role in the formation of tight junctions, which are specialized junctions that mediate the transfer of electrical signals between adjacent cells. During development, papilin is involved in the formation of the neural tube, and it is also expressed in the placenta, where it plays a critical role in the exchange of nutrients and oxygen between the mother and the developing fetus.

Papilin is a protein that has been identified as a potential drug target in the field of cancer. Its unique structure and function make it an attractive target for small molecule inhibitors. In this article, we will explore the biology of papilin and its potential as a drug target.

Papilin as a Drug Target

Papilin has been identified as a potential drug target in the field of cancer due to its unique structure and function. Its transmembrane domain and cytoplasmic domain make it an attractive target for small molecule inhibitors.

One of the key challenges in the development of drugs against papilin is the difficulty of targeting its transmembrane domain. Papilin's transmembrane domain is composed of a region of coiled-coil structures, which makes it difficult to develop small molecule inhibitors that specifically target this region. However, recent studies have identified a number of small molecules that are able to specifically target the transmembrane domain of papilin and are being further developed as potential drugs.

Another challenge in the development of drugs against papilin is the lack of understanding of its function in cancer. While papilin is involved in the regulation of cell signaling during development, its role in cancer is not well understood. Further research is needed to better understand the function of papilin in cancer and to identify small molecules that are able to specifically target its function.

Conclusion

Papilin is a protein that is expressed in the epithelial tissue of the body, including the skin, gut, and respiratory tract. It is a small, transmembrane glycoprotein that consists of two chains: chain A and chain B. Each chain has a distinct function, and together they form a complex structure that is essential for cell signaling and tissue structure.

Papilin is a key regulator of cell signaling, particularly in the context of cell-cell adhesion. It plays a vital role in the formation of tight junctions, which are specialized junctions that mediate the transfer of electrical signals between adjacent cells. During development, papilin is involved in the formation of the neural tube, and it is also expressed in the placenta, where it plays a critical role in the exchange of nutrients and oxygen between the mother and the developing fetus.

Papilin is also involved in the regulation of cell signaling, particularly in the context of cell-cell adhesion. It plays a vital role in the formation of tight junctions, which are specialized junctions that mediate the transfer of electrical signals between adjacent cells. During development, papilin is involved in the formation of the neural tube, and it is also expressed in the placenta, where it plays a critical role in the exchange of nutrients and oxygen between the mother and the developing fetus.

Papilin has been identified as a potential drug target in the field of cancer due to its unique structure and function. Its transmembrane domain and cytoplasmic domain make it an attractive target for small molecule inhibitors. However, the development of drugs against papilin is still in its early stages, and further research is needed to better understand its function in cancer and to identify small molecules that are able to specifically target its function.

Protein Name: Papilin, Proteoglycan Like Sulfated Glycoprotein

The "PAPLN Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about PAPLN comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets